Register Login

Still More on Dabigatran Risks

Here is a summary of the FDA’s adverse events report suggesting a higher case fatality rate than in the Mini-Sentinel report published in the March 13, 2013 New England Journal of Medicine. The argument continues.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply